Cdx2 Controls Expression of the Protocadherin Mucdhl, an Inhibitor of Growth and β-Catenin Activity in Colon Cancer Cells

被引:43
|
作者
Hinkel, Isabelle [1 ,2 ]
Duluc, Isabelle [1 ,2 ]
Martin, Elisabeth [1 ,2 ]
Guenot, Dominique [2 ,3 ]
Freund, Jean-Noel [1 ,2 ]
Gross, Isabelle [1 ,2 ]
机构
[1] INSERM, U682, F-67200 Strasbourg, France
[2] Univ Strasbourg, Fac Med, F-67081 Strasbourg, France
[3] EA4438, F-67085 Strasbourg, France
关键词
Tumor Suppressor; cdhr5; Colorectal Cancer; CRC; HOMEOBOX GENE; COLORECTAL-CANCER; MU-PROTOCADHERIN; STEM-CELLS; INTESTINE; MOUSE; CADHERIN; PROTEINS; PROLIFERATION; TRANSCRIPTION;
D O I
10.1053/j.gastro.2011.12.037
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: The intestine-specific homeobox transcription factor Cdx2 is an important determinant of intestinal identity in the embryonic endoderm and regulates the balance between proliferation and differentiation in the adult intestinal epithelium. Human colon tumors often lose Cdx2 expression, and heterozygous inactivation of Cdx2 in mice increases colon tumorigenesis. We sought to identify Cdx2 target genes to determine how it contributes to intestinal homeostasis. METHODS: We used expression profiling analysis to identify genes that are regulated by Cdx2 in colon cancer cells lines. Regulation and function of a potential target gene were further investigated using various cell assays. RESULTS: In colon cancer cell lines, Cdx2 directly regulated the transcription of the gene that encodes the protocadherin Mucdhl. Mucdhl localized to the apex of differentiated cells in the intestinal epithelium, and its expression was reduced in most human colon tumors. Overexpression of Mucdhl inhibited low-density proliferation of colon cancer cells and reduced tumor formation in nude mice. One isoform of Mucdhl interacted with beta-catenin and inhibited its transcriptional activity. CONCLUSIONS: The transcription factor Cdx2 activates expression of the protocadherin Mucdhl, which interacts with beta-catenin and regulates activities of intestinal cells. Loss of Cdx2 expression in colon cancer cells might reduce expression of Mucdhl and thereby lead to tumor formation.
引用
收藏
页码:875 / U335
页数:14
相关论文
共 50 条
  • [1] Effects of Homeodomain Protein CDX2 Expression on the Proliferation and Migration of Lovo Colon Cancer Cells
    Zheng, Jian-bao
    Sun, Xue-jun
    Qi, Jie
    Li, Shou-shuai
    Wang, Wei
    Ren, Hai-liang
    Tian, Yong
    Lu, Shao-ying
    Du, Jun-kai
    PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) : 743 - 751
  • [2] Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo
    Zheng, Jianbao
    He, Sai
    Qi, Jie
    Wang, Xiaolong
    Yu, Junhui
    Wu, Yunhua
    Gao, Qi
    Wang, Kai
    Sun, Xuejun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (02) : 478 - 488
  • [3] CDX2 expression and perioperative patient serum affects the adhesion properties of cultured colon cancer cells
    Davidsen, Johanne
    Jessen, Stine Bull
    Watt, Sara Kehlet
    Larsen, Sylvester
    Dahlgaard, Katja
    Kirkegaard, Tove
    Gogenur, Ismail
    Troelsen, Jesper T.
    BMC CANCER, 2020, 20 (01)
  • [4] Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells
    Olsen, Anders Kruger
    Coskun, Mehmet
    Bzorek, Michael
    Kristensen, Michael Holmsgaard
    Danielsen, Erik Thomas
    Jorgensen, Steffen
    Olsen, Jorgen
    Engel, Ulla
    Holck, Susanne
    Troelsen, Jesper Thorvald
    CARCINOGENESIS, 2013, 34 (06) : 1361 - 1369
  • [5] SMYD2 epigenetically activates MEX3A and suppresses CDX2 in colorectal cancer cells to augment cancer growth
    Pan, Lizhen
    Fan, Yuejuan
    Zhou, Lei
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (09) : 959 - 969
  • [6] CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression
    Yu, Junhui
    Liu, Dong
    Sun, Xuejun
    Yang, Kui
    Yao, Jianfeng
    Cheng, Chen
    Wang, Chunbao
    Zheng, Jianbao
    CELL DEATH & DISEASE, 2019, 10 (1)
  • [7] CDX2 as a Prognostic Biomarker in Colon Cancer REPLY
    Dalerba, Piero
    Sahoo, Debashis
    Clarke, Michael F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (22) : 2184 - 2184
  • [8] Evaluation of the Immunohistochemical Scoring System of CDX2 Expression as a Prognostic Biomarker in Colon Cancer
    Ilie-Petrov, Andreea-Corina
    Cristian, Daniel-Alin
    Grama, Florin Andrei
    Chitul, Andrei
    Blajin, Angela
    Popa, Andrei
    Mandi, Draga-Maria
    Welt, Luminita
    Bara, Marina Alina
    Vrincianu, Rares
    Ardeleanu, Carmen Maria
    DIAGNOSTICS, 2024, 14 (10)
  • [9] Stimulation of Cdx1 by oncogenic β-catenin/Tcf4 in colon cancer cells; opposite effect of the CDX2 homeoprotein
    Domon-Dell, C
    Freund, JN
    FEBS LETTERS, 2002, 518 (1-3) : 83 - 87
  • [10] CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
    Dalerba, Piero
    Sahoo, Debashis
    Paik, Soonmyung
    Guo, Xiangqian
    Yothers, Greg
    Song, Nan
    Wilcox-Fogel, Nate
    Forgo, Erna
    Rajendran, Pradeep S.
    Miranda, Stephen P.
    Hisamori, Shigeo
    Hutchison, Jacqueline
    Kalisky, Tomer
    Qian, Dalong
    Wolmark, Norman
    Fisher, George A.
    van de Rijn, Matt
    Clarke, Michael F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03) : 211 - 222